{"organizations": [], "uuid": "f20a4f20b5fab93ebead6633b8c8756b1371668a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/9", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/03/14/business-wire-bristol-myers-squibb-to-announce-results-for-first-quarter-2018-on-april-26.html", "country": "US", "domain_rank": 767, "title": "Bristol-Myers Squibb to Announce Results for First Quarter 2018 on April 26", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.961, "site_type": "news", "published": "2018-03-14T13:59:00.000+02:00", "replies_count": 0, "uuid": "f20a4f20b5fab93ebead6633b8c8756b1371668a"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/03/14/business-wire-bristol-myers-squibb-to-announce-results-for-first-quarter-2018-on-april-26.html", "ord_in_thread": 0, "title": "Bristol-Myers Squibb to Announce Results for First Quarter 2018 on April 26", "locations": [], "entities": {"persons": [], "locations": [{"name": "new york", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "nyse", "sentiment": "negative"}, {"name": "squibb company", "sentiment": "negative"}, {"name": "squibb bristol-myers squibb", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the first quarter of 2018 on Thursday, April 26, 2018. During a conference call at 10:30 a.m. EDT on April 26, company executives will review financial information and will address inquiries from investors and analysts.\nInvestors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com or by dialing in the U.S. toll free 323-794-2093 or international 866-548-4713, confirmation code: 4713257. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 1:30 p.m. EDT on April 26 through 1:30 p.m. EDT on, May 10, 2018. The replay will also be available through http://investor.bms.com or by dialing in the U.S. toll free 888-203-1112 or international 719-457-0820, confirmation code: 4713257.\nAbout Bristol-Myers Squibb\nBristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn , Twitter , and YouTube .\nView source version on businesswire.com : http://www.businesswire.com/news/home/20180314005119/en/\nBristol-Myers Squibb Company\nMedia:\nKen Dominski, 609-252-5251\nken.dominski@bms.com\nor\nLisa McCormick Lavery, 609-252-7602\nlisa.mccormicklavery@bms.com\nor\nInvestors:\nJohn Elicker, 609-252-4611\njohn.elicker@bms.com\nor\nTim Power, 609-252-7509\ntimothy.power@bms.com\nor\nBill Szablewski, 609-252-5894\nwilliam.szablewski@bms.com\nSource: Bristol-Myers Squibb Company", "external_links": ["http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Ftwitter.com%2Fbmsnews&esheet=51772827&newsitemid=20180314005119&lan=en-US&anchor=Twitter&index=6&md5=87328ce975575d1aae52410e32140edb", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Finvestor.bms.com&esheet=51772827&newsitemid=20180314005119&lan=en-US&anchor=http%3A%2F%2Finvestor.bms.com&index=2&md5=9769b61ea1b5fdde9d86ca16e6eaf3cf", "http://www.businesswire.com/news/home/20180314005119/en/", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.bms.com&esheet=51772827&newsitemid=20180314005119&lan=en-US&anchor=Bristol-Myers+Squibb+Company&index=1&md5=7383b34e785b152f0564ebcf9febba2f", "http://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fbristol-myers-squibb&esheet=51772827&newsitemid=20180314005119&lan=en-US&anchor=LinkedIn&index=5&md5=913ccf24baaccf390d4cf4147a9d9440", "http://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.youtube.com%2Fchannel%2FUCjFf4oKibYrHae2NZ_GPS6g&esheet=51772827&newsitemid=20180314005119&lan=en-US&anchor=YouTube&index=7&md5=e1526e431eb371a6d17afa7ce656d178", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.bms.com%2F&esheet=51772827&newsitemid=20180314005119&lan=en-US&anchor=BMS.com&index=4&md5=dca12ca7c04004caef5044a9ca4b4ddc", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Finvestor.bms.com&esheet=51772827&newsitemid=20180314005119&lan=en-US&anchor=http%3A%2F%2Finvestor.bms.com&index=3&md5=8a972a0d8493d5fec5d975ecad3bca64"], "published": "2018-03-14T13:59:00.000+02:00", "crawled": "2018-03-14T19:13:45.004+02:00", "highlightTitle": ""}